Pneumonia Therapeutics Market Size, Share, Growth Report 2032

Pneumonia Therapeutics Market

Pneumonia Therapeutics Market By Therapeutics (Prevention Vaccines And Treatment Drugs), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, And Online Pharmacy), By Region - Global And Regional Industry Overview, market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-3894 Published Date: Aug-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 10.49 Billion USD 22.60 Billion 8.9% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description And Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Pneumonia Therapeutics Market, 2016-2025 (USD Billion)
    • 2.2. Global Pneumonia Therapeutics Market: Snapshot
  •  
  • Chapter 3. Pneumonia Therapeutics Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Value Chain Analysis
    • 3.3. Market Drivers
      • 3.3.1. Increasing Prevalence Of Pneumococcal Disease
      • 3.3.2. Increasing Awareness
    • 3.4. Global Pneumonia Therapeutics market Restraints: Impact Analysis
      • 3.4.1. Very low therapy accessibility
    • 3.5. Opportunities
      • 3.5.1. Untapped Market
    • 3.6. Porter's Five Forces Analysis
      • 3.6.1. Bargaining Power Of Suppliers
      • 3.6.2. Bargaining Power Of Buyers
      • 3.6.3. The Threat From New Entrants
      • 3.6.4. The threat From New Substitutes
      • 3.6.5. Degree Of Competition
    • 3.7. Market Attractiveness Analysis
      • 3.7.1. Market Attractiveness Analysis, by Therapeutics
      • 3.7.2. Market Attractiveness Analysis, by Region
  •  
  • Chapter 4. Global Pneumonia Therapeutics market - Competitive Landscape
    • 4.1. Company Market Share, 2018 (Subject To Data Availability)
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Source Launch
      • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
      • 4.2.4. Research And Development and Regional Expansion
  •  
  • Chapter 5. Global Pneumonia Therapeutics market - Therapeutics Analysis
    • 5.1. Global Pneumonia Therapeutics market: Therapeutics Overview
      • 5.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Therapeutics, 2018 and 2025
    • 5.2. Prevention Vaccines
      • 5.2.1. Global Pneumonia Therapeutics market for Prevention Vaccines, 2016-2025 (USD Billion)
    • 5.3. Treatment Drugs
      • 5.3.1. Global Pneumonia Therapeutics market for Treatment Drugs, 2016-2025 (USD Billion)
  •  
  • Chapter 6. Global Pneumonia Therapeutics market - Distribution Channel Analysis
    • 6.1. Global Pneumonia Therapeutics market: Distribution Channel Overview
      • 6.1.1. Global Pneumonia Therapeutics Market Revenue Share, By Distribution Channel, 2018 and 2025
    • 6.2. Hospital Pharmacy
      • 6.2.1. Global Pneumonia Therapeutics market for Hospital Pharmacy, 2016-2025 (USD Billion)
    • 6.3. Retail Pharmacy
      • 6.3.1. Global Pneumonia Therapeutics market for Retail Pharmacy, 2016-2025 (USD Billion)
    • 6.4. Online Pharmacy
      • 6.4.1. Global Pneumonia Therapeutics market for Online Pharmacy, 2016-2025 (USD Billion)
  •  
  • Chapter 7. Global Pneumonia Therapeutics Market: Regional overview
    • 7.1.. Global Pneumonia Therapeutics Market revenue share, by Region, 2018 and 2025
    • 7.2. North America
      • 7.2.1. North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.2.2. North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.3. The U.S.
        • 7.2.3.1. The U.S. Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.3.2. The U.S. Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.2.4. Rest of North America
        • 7.2.4.1. Rest of North America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.2.4.2. Rest of North America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.3. Europe
      • 7.3.1. Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.3.2. Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.3. UK
        • 7.3.3.1. UK Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.3.2. UK Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.4. Germany
        • 7.3.4.1. Germany Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.4.2. Germany Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.5. France
        • 7.3.5.1. France Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.5.2. France Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.3.6. Rest of Europe
        • 7.3.6.1. Rest of Europe Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.3.6.2. Rest of Europe Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.4.2. Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.3. China
        • 7.4.3.1. China Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.3.2. China Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.4. Japan
        • 7.4.4.1. Japan Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.4.2. Japan Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.5. India
        • 7.4.5.1. India Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.5.2. India Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.4.6. Rest of Asia Pacific
        • 7.4.6.1. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.4.6.2. Rest of Asia Pacific Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.5. Latin America
      • 7.5.1. Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.5.2. Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.3. Brazil
        • 7.5.3.1. Brazil Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.3.2. Brazil Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
      • 7.5.4. Rest of Latin America
        • 7.5.4.1. Rest of Latin America Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
        • 7.5.4.2. Rest of Latin America Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
    • 7.6. The Middle East and Africa
      • 7.6.1. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Therapeutics, 2016-2025 (USD Billion)
      • 7.6.2. The Middle East and Africa Pneumonia Therapeutics Market revenue, by Distribution Channel, 2016-2025 (USD Billion)
  •  
  • Chapter 8. Company Profiles
    • 8.1. GlaxoSmithKline
      • 8.1.1. Overview
      • 8.1.2. Financial overview
      • 8.1.3. Therapeutics Portfolio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Merck & Co.
      • 8.2.1. Overview
      • 8.2.2. Financial Overview
      • 8.2.3. Therapeutics Portfolio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Novartis AG
      • 8.3.1. Overview
      • 8.3.2. Financial Overview
      • 8.3.3. Therapeutics Portfolio
      • 8.3.4. Business strategy
      • 8.3.5. Recent Developments
    • 8.4. Sanofi
      • 8.4.1. Overview
      • 8.4.2. Financial Overview
      • 8.4.3. Therapeutics Portfolio
      • 8.4.4. Business strategy
      • 8.4.5. Recent Developments
    • 8.5. Eli Lilly and Company
      • 8.5.1. Overview
      • 8.5.2. Financial Overview
      • 8.5.3. Therapeutics Portfolio
      • 8.5.4. Business strategy
      • 8.5.5. Recent Developments
    • 8.6. AstraZeneca
      • 8.6.1. Overview
      • 8.6.2. Financial Overview
      • 8.6.3. Therapeutics Portfolio
      • 8.6.4. Business strategy
      • 8.6.5. Recent Developments
    • 8.7. Pfizer
      • 8.7.1. Overview
      • 8.7.2. Financial Overview
      • 8.7.3. Therapeutics Portfolio
      • 8.7.4. Business strategy
      • 8.7.5. Recent Developments
    • 8.8. Baxter International Inc.
      • 8.8.1. Overview
      • 8.8.2. Financial Overview
      • 8.8.3. Therapeutics Portfolio
      • 8.8.4. Business strategy
      • 8.8.5. Recent Developments
    • 8.9. Lupin Pharmaceuticals Inc.
      • 8.9.1. Overview
      • 8.9.2. Financial Overview
      • 8.9.3. Therapeutics Portfolio
      • 8.9.4. Business strategy
      • 8.9.5. Recent Developments
    • 8.10. Allergan
      • 8.10.1. Overview
      • 8.10.2. Financial Overview
      • 8.10.3. Therapeutics Portfolio
      • 8.10.4. Business strategy
      • 8.10.5. Recent Developments

Table Of Figures

List of Figures 

1. Market Research Process
2. Market Research Methodology
3. Global Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Market Attractiveness Analysis by Therapeutics
6. Market Attractiveness Analysis by Distribution Channel
7. Market Attractiveness Analysis by Region
8. Global Pneumonia Therapeutics Market Revenue Share, By Therapeutics, 2016–2025 (USD Billion)
9. Global Pneumonia Therapeutics Market For Prevention Vaccines, 2016–2025 (USD Billion)
10. Global Pneumonia Therapeutics Market For Treatment Drugs, 2016–2025 (USD Billion)
11. Global Pneumonia Therapeutics Market Revenue Share, By Distribution Channel, (USD Billion)
12. Global Pneumonia Therapeutics Market For Hospital Pharmacy, 2016–2025 (USD Billion)
13. Global Pneumonia Therapeutics Market For Retail Pharmacy, 2016–2025 (USD Billion)
14. Global Pneumonia Therapeutics Market For Online Pharmacy, 2016–2025 (USD Billion)
15. North America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
16. The U.S. Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
17. Rest of North America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
18. Europe Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
19. UK Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
20. Germany Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
21. France Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
22. Rest of Europe Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
23. Asia Pacific Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
24. China Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
25. Japan Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
26. India Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
27. Rest of Asia Pacific Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
28. Latin America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
29. Brazil Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
30. Rest of Latin America Pneumonia Therapeutics Market, 2016–2025 (USD Billion)
31. The Middle East and Africa Pneumonia Therapeutics Market, 2016–2025 (USD Billion)


Table Of Tables

List of Tables

1. Global Pneumonia Therapeutics Market: Snapshot
2. Drivers Of The Pneumonia Therapeutics Market: Impact Analysis
3. Restraints For The Pneumonia Therapeutics Market: Impact Analysis
4. North America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
5. North America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
6. The U.S. Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
7. The U.S. Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
8. Rest of North America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
9. Rest of North America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
10. Europe Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
11. Europe Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
12. UK Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
13. UK Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
14. Germany Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
15. Germany Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
16. France Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
17. France Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
18. Rest of Europe Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
19. Rest of Europe Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
20. China Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
21. China Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
22. Japan Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
23. Japan Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
24. India Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
25. India Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
26. Rest of Asia Pacific Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
27. Rest of Asia Pacific Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
28. Latin America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
29. Latin America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
30. Brazil Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
31. Brazil Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
32. Rest of Latin America Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
33. Rest of Latin America Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)
34. The Middle East and Africa Pneumonia Therapeutics Market Revenue, By Therapeutics, 2016–2025 (USD Billion)
35. The Middle East and Africa Pneumonia Therapeutics Market Revenue, By Distribution Channel, 2016–2025 (USD Billion)

Methodology

FrequentlyAsked Questions

Pneumonia therapeutics encompass a range of treatments designed to manage and cure pneumonia, an infection that inflames the air sacs in one or both lungs. 

According to study, the Pneumonia Therapeutics market size was worth around USD 10.49 billion in 2023 and is predicted to grow to around USD 22.60 billion by 2032.
 

The CAGR value of Pneumonia Therapeutics market is expected to be around 8.9% during 2024-2032.

North America has been leading the Pneumonia Therapeutics market and is anticipated to continue on the dominant position in the years to come.
 

The Pneumonia Therapeutics market is led by players likeGlaxoSmithKline, Sanofi, Merck & Co. Inc., Novartis AG, Eli Lilly and Company, AstraZeneca, Merck & Co., Pfizer, Baxter International Inc., Allergan, and Lupin Pharmaceuticals Inc., among others

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed